Fluticasone Propionate DPI for Wheezing

The American College of Allergy recommends dosing fluticasone propionate DPI at 88-264 mcg twice daily for adults with asthma, with specific dosing based on severity 1
For adults and adolescents with asthma, a low dose of 88-264 mcg/day (divided twice daily) is recommended 1
For children (5-11 years) with asthma, a low dose of 88-176 mcg/day (divided twice daily) is recommended 1
The dose should be titrated upward if peak expiratory flow (PEF) remains <80% of predicted or personal best 3, 4
Step down therapy once control is achieved for at least 3 months, reducing to the minimum dose that maintains symptom control 1

The European Respiratory Society recommends that fluticasone propionate should NOT be first-line therapy for COPD wheezing, but can be used for patients with severe disease (FEV1 <50% predicted) and frequent exacerbations (≥2 per year) 2, 5
For COPD patients with severe disease, fluticasone propionate can be used at a dose of 250-500 mcg twice daily, preferably in fixed-dose combination with salmeterol 2
Increased risk of pneumonia occurs with inhaled corticosteroids in COPD patients, and this risk must be weighed against exacerbation reduction benefits 2, 5

Acute Exacerbations with Wheezing

For acute severe asthma with wheezing, nebulized beta-agonist (salbutamol 5 mg or terbutaline 10 mg) every 4-6 hours, oral corticosteroids (30 mg prednisolone daily), and oxygen to maintain saturation are recommended 3, 5, 6
For acute COPD exacerbations with increased wheezing, mild cases can be treated with hand-held inhaler with salbutamol 200-400 mcg or terbutaline 500-1000 mcg, while severe cases require nebulized salbutamol 2.5-5 mg or terbutaline 5-10 mg every 4-6 hours for 24-48 hours 4, 7

Proper DPI technique is essential, and patients must generate adequate inspiratory flow for effective drug delivery 1
Monitor for oral candidiasis, and advise patients to rinse mouth after each dose 1
Avoid high-flow oxygen with nebulizers in COPD patients with CO2 retention, and use air-driven nebulizers with supplemental oxygen via nasal cannulae if needed 4, 6